Skip to main content

Peer Review reports

From: Tofacitinib for the treatment of inflammatory bowel disease-associated arthritis: two case reports

Original Submission
3 Apr 2022 Submitted Original manuscript
8 Jan 2023 Reviewed Reviewer Report - Abu Bakar Siddiq
13 Jan 2023 Reviewed Reviewer Report - Chinmoy Bose
28 Jan 2023 Author responded Author comments - Muhammad Shoaib Momen Majumder
Resubmission - Version 2
28 Jan 2023 Submitted Manuscript version 2
Publishing
30 Jan 2023 Editorially accepted
1 Mar 2023 Article published 10.1186/s13256-023-03796-2

You can find further information about peer review here.

Back to article page